Best Supplements for Mood & Stress: Evidence-Based Rankings
Mood disorders and chronic stress affect millions of people worldwide, creating a substantial burden on mental health and overall quality of life. While conventional treatments like cognitive-behavioral therapy (CBT) and selective serotonin reuptake inhibitors (SSRIs) remain first-line interventions, many individuals seek complementary approaches to support their mental health. This has sparked growing interest in dietary supplements that claim to enhance mood and reduce stress.
However, not all supplements are created equal. The supplement industry is crowded with products making extraordinary claims based on minimal evidence, outdated research, or cherry-picked studies. This is why evidence-based evaluation is crucial. By examining rigorous randomized controlled trials (RCTs), meta-analyses, and systematic reviews, we can distinguish between supplements with genuine clinical promise and those lacking scientific support.
This comprehensive ranking evaluates the most popular mood and stress supplements using a tiered evidence system. Each supplement is assessed based on the quality and consistency of human clinical trials, effect sizes, sample sizes, and the practical implications for real-world use. Whether you're managing generalized anxiety, depression, stress-related symptoms, or simply seeking to optimize your mental health, this guide provides actionable information grounded in clinical science.
Supplements are ranked by evidence quality, not popularity or price. A Tier 4 rating indicates clinically meaningful efficacy supported by multiple well-designed RCTs and consistent meta-analytic findings. Tier 3 ratings indicate probable but not conclusive efficacy, with promising evidence that requires additional confirmation through larger or more rigorous studies.
What It Is:
Ashwagandha (Withania somnifera) is an adaptogenic herb from traditional Ayurvedic medicine. It contains bioactive compounds called withanolides, which are believed to modulate the hypothalamic-pituitary-adrenal (HPA) axis—the body's central stress-response system.
Evidence Tier: Tier 4 (Clinically Meaningful Efficacy)
Key Clinical Findings:
A meta-analysis of 12 rigorous randomized controlled trials involving 1,002 participants found that ashwagandha significantly reduced anxiety symptoms with a standardized mean difference (SMD) of -1.55 (95% confidence interval: -2.37 to -0.74). The same analysis found stress reduction with an SMD of -1.75 (95% CI: -2.29 to -1.22)—both representing large effect sizes that translate to meaningful clinical improvement.
A second meta-analysis examining 9 RCTs with 558 participants showed even more specific benefits:
- Perceived Stress Scale reduced by 4.72 points (95% CI: -8.45 to -0.99)
- Hamilton Anxiety Scale reduced by 2.19 points (95% CI: -3.83 to -0.55)
- Serum cortisol (the stress hormone) decreased by 2.58 nmol/L (95% CI: -4.99 to -0.16)
These results were consistent across diverse populations, including healthy individuals under stress, those with diagnosed anxiety disorders, and individuals with other health conditions.
Optimal Dosing: 300–600 mg once daily or split into two doses (oral)
Cost: $15–$45 per month
Who It's Best For:
- Individuals with generalized anxiety disorder or social anxiety
- Those experiencing high perceived stress
- People seeking a non-prescription alternative to anxiolytics
- Anyone with elevated cortisol levels related to chronic stress
Why It Ranks Highest:
Ashwagandha has the most robust and consistent evidence base of any mood/stress supplement. Multiple large, well-designed trials and meta-analyses consistently demonstrate clinically meaningful reductions in both subjective stress measures and objective biomarkers like cortisol. The dose-response relationship (optimal at 300–600 mg/day) is also well-established.
What It Is:
Creatine monohydrate is a natural compound produced by the body and found in foods like red meat and fish. It supports cellular energy production through the phosphocreatine system and crosses the blood-brain barrier, potentially supporting mood regulation and cognitive function.
Evidence Tier: Tier 3 (Probable Efficacy with Limited Evidence)
Key Clinical Findings:
In a double-blind RCT with 52 women diagnosed with major depressive disorder, creatine monohydrate (5 g/day) combined with the antidepressant escitalopram produced significantly greater improvements in Hamilton Depression (HAM-D) scores compared to placebo combined with the same SSRI. Benefits appeared as early as week 2 and persisted through week 8.
In a separate double-blind RCT with 35 participants, creatine monohydrate (6 g/day) used as an adjunct to bipolar depression treatment achieved a 52.9% remission rate (defined as MADRS scores ≤12) at 6 weeks, compared to only 11.1% in the placebo group.
Important caveat: These studies examined creatine as an adjunct to conventional psychiatric medications, not as a standalone treatment. Evidence for creatine's efficacy in healthy individuals without clinical depression is limited.
Optimal Dosing: 3–5 g once daily (oral)
Cost: $8–$25 per month
Who It's Best For:
- Individuals already taking SSRIs or other antidepressants who want to enhance treatment response
- People with bipolar disorder (under medical supervision)
- Those with comorbid cognitive symptoms alongside depression
- Athletes or active individuals (creatine also supports muscle performance)
Important Note:
Creatine supplementation may slightly increase creatinine levels, which are monitored in kidney function tests. Anyone with existing kidney disease should consult a healthcare provider before use.
What It Is:
Omega-3 polyunsaturated fatty acids, particularly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are essential nutrients found in fatty fish, algae, and marine supplements. These fats are structural components of cell membranes and support neurotransmitter function and brain inflammation regulation.
Evidence Tier: Tier 3 (Probable but Inconsistent Benefits)
Key Clinical Findings:
A recent RCT examined fish oil and krill oil supplementation in 50 adults diagnosed with major depressive disorder over 8 weeks. Both formulations significantly reduced Hamilton Depression Rating Scale (HDRS) scores by 8.5–10.0 points compared to placebo (p<0.001). This represents a clinically meaningful reduction.
However, a large-scale prevention trial following 18,353 US adults over approximately 5 years (VITAL-DEP) found that long-term omega-3 supplementation (1 g/day fish oil) did not reduce the risk of incident or recurrent depression. This suggests omega-3s may be more effective for treating existing depression than preventing new cases.
Optimal Dosing: 1,000–4,000 mg EPA+DHA combined, once daily or divided twice daily (oral)
Cost: $10–$60 per month (varies significantly by quality and concentration)
Who It's Best For:
- Individuals with diagnosed major depressive disorder, especially those already on antidepressants
- People with inflammatory conditions or elevated inflammatory markers
- Those with inadequate dietary fish consumption
- Individuals seeking cardiovascular and cognitive benefits alongside mood support
Why Evidence Is Mixed:
Omega-3s appear more beneficial in clinical populations (those with diagnosed depression) than in prevention trials with asymptomatic populations. Effect sizes are modest, and outcomes vary based on baseline depression severity and baseline omega-3 status.
What It Is:
Magnesium is a critical mineral cofactor for over 300 enzymatic reactions in the body, including neurotransmitter synthesis and HPA axis regulation. It activates GABA receptors, the brain's primary inhibitory neurotransmitter system, which supports relaxation and anxiety reduction.
Evidence Tier: Tier 3 (Probable Efficacy in Vulnerable Populations)
Key Clinical Findings:
In an RCT with 112 adults with mild-to-moderate depression, magnesium chloride supplementation (248 mg/day for 6 weeks) produced a net improvement of -6.0 points on the PHQ-9 depression scale (95% CI: -7.9 to -4.2, p<0.001) and -4 points on the GAD-7 anxiety scale compared to placebo.
In a separate RCT with 60 cardiac surgery patients, magnesium supplementation (500 mg/day for 5 days) significantly reduced anxiety and depression measured by the Hospital Anxiety and Depression Scale (HADS; p=0.007) and improved sleep quality on the Pittsburgh Sleep Quality Index (PSQI; p=0.001).
Optimal Dosing: 200–400 mg elemental magnesium once daily (oral). Note: "elemental" magnesium is the actual magnesium content; chelated forms like glycinate may be better absorbed.
Cost: $12–$45 per month
Who It's Best For:
- Individuals with concurrent magnesium deficiency (often indicated by muscle cramps, poor sleep, or tension)
- Those with mild-to-moderate anxiety or depression (not severe cases)
- People seeking natural sleep support alongside mood benefits
- Those with high stress or muscle tension
Caveat:
Evidence is limited by small sample sizes and relatively short intervention periods. Magnesium's benefits appear modest, and responsiveness varies among individuals.
What It Is:
Vitamin D3 is a hormone-like nutrient synthesized in the skin upon sun exposure and obtained from food sources like fatty fish, egg yolks, and mushrooms. It plays crucial roles in immune function, calcium homeostasis, and neurobiological processes including dopamine and serotonin synthesis.
Evidence Tier: Tier 3 (Probable but Inconsistent Benefits)
Key Clinical Findings:
An RCT with 56 patients with mild-to-moderate depression found that vitamin D3 supplementation (50,000 IU every 2 weeks for 8 weeks) reduced BDI-II depression scores by 11.75±6.40 points, compared to only 3.61±10.40 points in the placebo group (p=0.003).
However, the large-scale VITAL-DEP trial following 18,353 participants over a mean of 5.6 years found that vitamin D3 supplementation (2,000 IU/day) did not significantly reduce incident depression or clinically relevant depressive symptoms compared to placebo.
Optimal Dosing: 2,000–5,000 IU once daily (oral). Higher doses (up to 10,000 IU) may be appropriate for severely deficient individuals, but blood levels should be monitored.
Cost: $5–$20 per month
Who It's Best For:
- Individuals with documented vitamin D deficiency (<20 ng/mL) or insufficiency (<30 ng/mL)
- Those with limited sun exposure or living in high-latitude climates
- People with seasonal affective disorder (SAD)
- Anyone seeking immune and bone health benefits alongside mood support
Why Evidence Is Mixed:
The discrepancy between the smaller RCT (showing benefit) and the large prevention trial (showing no benefit) suggests vitamin D3 may be most effective in deficient or insufficient populations rather than as a universal preventive for mood disorders.
What It Is:
Curcumin is the primary active polyphenol extracted from turmeric (Curcuma longa), a spice used in traditional medicine. It exhibits potent anti-inflammatory and antioxidant properties and crosses the blood-brain barrier to support neuroplasticity and reduce neuroinflammation.
Evidence Tier: Tier 3 (Probable Efficacy for Anxiety)
Key Clinical Findings:
A meta-analysis of 8 RCTs involving 567 participants found that curcumin significantly reduced anxiety disorder symptoms with a large standardized mean difference (SMD: -1.56, 95% CI: -2.48 to -0.64, p<0.001). This effect size is comparable to ashwagandha and represents clinically meaningful improvement.
However, evidence for broader mood and stress benefits is mixed. In an RCT with 65 migraine patients, phytosomal curcumin (250 mg/day for 8 weeks) reduced stress scores and improved quality of life and sleep quality (p<0.05 to p<0.01), but depression and anxiety scores showed no significant change (p>0.05).
Optimal Dosing: 500–1,000 mg twice daily (oral). Look for "phytosomal" or "BCM-95" formulations, which have superior bioavailability compared to standard curcumin extract.
Cost: $10–$55 per month
Who It's Best For:
- Individuals with diagnosed anxiety disorders
- Those with comorbid inflammatory conditions (arthritis, inflammatory bowel disease)
- People seeking cognitive benefits alongside anxiety reduction
- Those interested in general anti-inflammatory and antioxidant support
Bioavailability Consideration:
Standard curcumin has poor intestinal absorption. Enhanced formulations (phytosomal, BCM-95, or those combined with black pepper extract containing piperine) dramatically improve bioavailability and should be preferred.
What It Is:
Probiotics are beneficial live bacteria and fungi that colonize the gut microbiome. The "psychobiotic" concept refers to probiotic strains that cross the gut-brain axis and influence mood, stress, and cognitive function through microbial metabolite production, immune modulation, and vagal signaling.
Evidence Tier: Tier 3 (Probable but Inconsistent Benefits)
Key Clinical Findings:
A meta-analysis examining probiotic supplementation across multiple studies found significant reductions in depressive symptoms (SMD = -0.87; 95% CI: -1.66 to -0.99; p=0.03). However, the same analysis found no significant difference for anxiety or stress symptoms across the 23 studies analyzed, highlighting inconsistency.
In a fibromyalgia RCT, probiotic supplementation (4×10^10 CFU/day for 8 weeks) significantly decreased Beck Depression Index, Beck Anxiety Index, and Pittsburgh Sleep Quality Index compared to baseline, whereas prebiotic-only supplementation reduced only sleep quality.
Optimal Dosing: 10–100 billion CFU (colony-forming units) once daily (oral). Multi-strain formulations containing Lactobacillus and Bifidobacterium species appear most promising.
Cost: $15–$80 per month (varies widely by strain diversity and CFU count)
Who It's Best For:
- Individuals with diagnosed depression, especially those with concurrent GI symptoms
- Those with dysbiotic microbiota (history of antibiotic use, poor diet, IBS)
- People seeking concurrent mood and digestive health benefits
- Those interested in the growing psychobiotic research area
Caveat:
Evidence remains inconsistent across studies, effect sizes are modest, and mechanisms are not fully established. Strain selection matters significantly, but there's insufficient evidence to recommend specific strains universally.
What It Is:
Rhodiola rosea is an adaptogenic herb containing phenolic compounds and rosavins that modulate the HPA axis and support dopamine and serotonin systems. Traditional use emphasizes resilience to physical and psychological stress.
Evidence Tier: Tier 3 (Probable Efficacy with Small Sample Sizes)
Key Clinical Findings:
An RCT with 80 mildly anxious participants found significant reductions in self-reported anxiety, stress, anger, confusion, and depression at 14 days of supplementation.
In a separate double-blind RCT with 60 participants diagnosed with stress-related fatigue, the standardized extract SHR-5 (576 mg/day) improved quality of life measured by SF-36 and depression symptoms measured by MADRS after 28 days compared to placebo.
Optimal Dosing: 300–600 mg once or twice daily (oral). Standardized extracts containing 3% rosavins and 1% salidroside are preferred.
Cost: $12–$40 per month